
51 - 200 funcionários
Fundada em 2005
🧬 Biotecnologia
💊 Farmacêutico
🔬 Ciência
Biotechnology • Pharmaceuticals • Science
A Capricor Therapeutics, Inc. é uma empresa de biotecnologia em estágio clínico que desenvolve terapias baseadas em células e exossomos, focada em medicina de precisão para distrofia muscular de Duchenne e outras doenças graves. A empresa avança com células derivadas de cardiosferas alogênicas (CDCs) e plataformas de exossomos em um pipeline de múltiplas etapas, incluindo terapia celular investigativa (deramiocel) e abordagens para carregar oligonucleotídeos terapêuticos em exossomos. A Capricor enfatiza o desenvolvimento centrado no paciente, pesquisa translacional e parcerias estratégicas para trazer novos medicamentos biológicos aos pacientes.
🕒 Junho 2
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

51 - 200 funcionários
Fundada em 2005
🧬 Biotecnologia
💊 Farmacêutico
🔬 Ciência
Biotechnology • Pharmaceuticals • Science
A Capricor Therapeutics, Inc. é uma empresa de biotecnologia em estágio clínico que desenvolve terapias baseadas em células e exossomos, focada em medicina de precisão para distrofia muscular de Duchenne e outras doenças graves. A empresa avança com células derivadas de cardiosferas alogênicas (CDCs) e plataformas de exossomos em um pipeline de múltiplas etapas, incluindo terapia celular investigativa (deramiocel) e abordagens para carregar oligonucleotídeos terapêuticos em exossomos. A Capricor enfatiza o desenvolvimento centrado no paciente, pesquisa translacional e parcerias estratégicas para trazer novos medicamentos biológicos aos pacientes.
• Develop and execute the territory KOL/HCP engagement plan, including identification, mapping, and prioritization of thought leaders, prescribers and treatment centers.**• Deliver scientific presentations and engage in scientific exchange with KOLs and HCPs on Deramiocel clinical data, the DMD cardiomyopathy landscape, and emerging evidence.**• Support advisory boards, scientific symposia, and KOL-led research initiatives.**• Identify and support investigator-initiated studies (IIS) and real-world evidence opportunities in coordination with HEOR / RWE and Medical Director.**• Provide scientific support for medical congresses, including DMD, neuromuscular, cardiology, and rare-disease forums.**• Collect and synthesize field insights on clinical practice, treatment decision-making, and emerging evidence; translate insights into recommendations for medical strategy.**• Provide scientific training and support to internal stakeholders (Sales, Market Access, Patient Services) in compliance with channel and engagement rules.**• Maintain comprehensive scientific fluency on Deramiocel clinical data, DMD natural history, and the broader treatment landscape.**• Ensure timely reporting of adverse events and product complaints in line with company and regulatory processes.**• Document field activities, KOL/HCP engagement, and insights in Capricor's medical CRM in compliance with standards.**• Ensure all activities follow FDA, OIG, PhRMA Code, ACCME, and Capricor compliance standards.**• Perform other duties as may be assigned from time to time.
• Advanced clinical degree required (MD, PharmD, PhD, DO, or equivalent).**• 5 to 10 years of MSL experience in biotech / pharma; experience in rare disease, cell / gene therapy, pediatrics, neuromuscular disease, or cardiology preferred.**• Established scientific credibility and ability to engage KOLs in peer-to-peer scientific exchange.**• Strong working knowledge of FDA, OIG, PhRMA Code, ACCME, and MLR review processes.**• Excellent written and verbal scientific communication skills, including ability to deliver complex data to clinical audiences.**• Self-directed execution and the ability to operate independently in a field-based environment.
• Collaborative environment for professional growth and innovation
Candidatar-se🕒 Junho 2
Director of Strategic Transactions for global M&A transactions at Ciena. Collaborating with leadership to execute strategic acquisitions and partnerships.
🇺🇸 Estados Unidos – Remoto (EUA)
💰 Series C em 1995-12
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Junho 2
Director of Consumer overseeing charity: water's recurring giving growth and managing paid media strategies. Leading donor engagement and maximizing financial contributions to support clean water initiatives.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Junho 2
Director responsible for driving commercial growth and shaping software compliance advisory services. Leading strategic client relationships within a specialist advisory firm.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Junho 2
Director of Commercial Data & Analytics overseeing commercial analytics strategy for rare disease portfolio. Collaborating with cross-functional stakeholders to translate business strategies into measurable insights.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Junho 2
Director of Support leading a customer-centric support organization for Crunchafi, a cloud-based accounting solutions provider. Overseeing team development, process design, and performance management.
🗣️🇺🇸🇬🇧 Inglês obrigatório